Clinical trial
A Non-interventional Observational Post Authorization Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands (OCEAN)
NCT02891551 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-interventional Observational Post Authorization Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands (OCEAN)
- Lead sponsor
- Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2012
- Completion date
- December 30, 2018
- Enrollment
- 209 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.